Opsy Holding（OPSYH）株式概要オプシー・ホールディングABは、医療と保険の交差点でソリューションを開発するハイテク企業である。 詳細OPSYH ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6報酬過去 1 年間で収益は79.1%増加しましたリスク分析Swedish市場と比較して、過去 3 か月間の株価の変動が非常に大きいマイナスの株主資本 キャッシュランウェイが1年未満である 意味のある時価総額がありません ( SEK148M )+2 さらなるリスクすべてのリスクチェックを見るOPSYH Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW468,393 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA468,393 investors already sharing narrativesYour Fair ValueSEK Current PriceSEK 10.20374.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-28m11m2016201920222025202620282031Revenue SEK 11.2mEarnings SEK 1.3mAdvancedSet Fair ValueView all narrativesOpsy Holding AB (publ) 競合他社ModelonSymbol: OM:MODELMarket cap: SEK 164.0mNowonomicsSymbol: NGM:NOWOMarket cap: SEK 140.3mKlimatorSymbol: OM:KLIMATMarket cap: SEK 131.1mOODA AISymbol: OM:OODAMarket cap: SEK 132.3m価格と性能株価の高値、安値、推移の概要Opsy Holding過去の株価現在の株価SEK 10.2052週高値SEK 17.4052週安値SEK 5.05ベータ01ヶ月の変化-2.86%3ヶ月変化-4.67%1年変化51.11%3年間の変化n/a5年間の変化n/aIPOからの変化113.84%最新ニュースNew Risk • Aug 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.1m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr134.7m market cap, or US$14.2m).お知らせ • Jul 29Opsy Holding AB (publ) to Report Q2, 2026 Results on Aug 27, 2026Opsy Holding AB (publ) announced that they will report Q2, 2026 results on Aug 27, 2026Recent Insider Transactions • May 19CEO & Director recently bought kr161k worth of stockOn the 12th of May, Arne Thor bought around 17k shares on-market at roughly kr9.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr658k worth in shares.Recent Insider Transactions • May 06CEO & Director recently bought kr139k worth of stockOn the 27th of April, Arne Thor bought around 18k shares on-market at roughly kr7.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr462k worth in shares.New Risk • Apr 27New major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr587k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.2m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr97.1m market cap, or US$10.5m).お知らせ • Apr 02Opsy Holding AB (publ) to Report Q1, 2026 Results on Apr 24, 2026Opsy Holding AB (publ) announced that they will report Q1, 2026 results on Apr 24, 2026最新情報をもっと見るRecent updatesNew Risk • Aug 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.1m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr134.7m market cap, or US$14.2m).お知らせ • Jul 29Opsy Holding AB (publ) to Report Q2, 2026 Results on Aug 27, 2026Opsy Holding AB (publ) announced that they will report Q2, 2026 results on Aug 27, 2026Recent Insider Transactions • May 19CEO & Director recently bought kr161k worth of stockOn the 12th of May, Arne Thor bought around 17k shares on-market at roughly kr9.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr658k worth in shares.Recent Insider Transactions • May 06CEO & Director recently bought kr139k worth of stockOn the 27th of April, Arne Thor bought around 18k shares on-market at roughly kr7.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr462k worth in shares.New Risk • Apr 27New major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr587k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.2m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr97.1m market cap, or US$10.5m).お知らせ • Apr 02Opsy Holding AB (publ) to Report Q1, 2026 Results on Apr 24, 2026Opsy Holding AB (publ) announced that they will report Q1, 2026 results on Apr 24, 2026Recent Insider Transactions • Jan 16CEO & Director recently bought kr323k worth of stockOn the 13th of January, Arne Thor bought around 47k shares on-market at roughly kr6.91 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Arne's only on-market trade for the last 12 months.お知らせ • Jan 13Opsy Holding AB (publ) to Report Fiscal Year 2025 Results on Feb 12, 2026Opsy Holding AB (publ) announced that they will report fiscal year 2025 results on Feb 12, 2026お知らせ • Oct 29Opsy Holding AB to Report Q3, 2025 Results on Nov 27, 2025Opsy Holding AB announced that they will report Q3, 2025 results on Nov 27, 2025お知らせ • Oct 16Opsy Holding AB announced that it expects to receive SEK 3.499991 million in funding from Juristfirma Erik Norman Aktiebolag, Alsteron ABOpsy Holding AB announced a private placement to issue 478,795 shares at a price of SEK 7.31 for aggregate gross proceeds of SEK 3,499,991.45 on October 15, 2025. The transaction will include participation from Erik Norman for 273,597 shares and Alsteron AB for 205,198 shares. The transaction has been approved by the board of directors and is subject to the Annual general Meeting of shareholders that is scheduled to be held on November 4, 2025. Post issuance, the share capital of the company will increase from SEK 12,218,223 to SEK 12,697,018.お知らせ • Jul 23Opsy Holding AB to Report Q2, 2025 Results on Aug 21, 2025Opsy Holding AB announced that they will report Q2, 2025 results on Aug 21, 2025お知らせ • Apr 29Opsy Holding AB to Report Q1, 2025 Results on May 28, 2025Opsy Holding AB announced that they will report Q1, 2025 results on May 28, 2025株主還元OPSYHSE SoftwareSE 市場7D2.0%1.6%0.6%1Y51.1%-12.1%11.2%株主還元を見る業界別リターン: OPSYH過去 1 年間で-12.1 % の収益を上げたSwedish Software業界を上回りました。リターン対市場: OPSYH過去 1 年間で11.2 % の収益を上げたSwedish市場を上回りました。価格変動Is OPSYH's price volatile compared to industry and market?OPSYH volatilityOPSYH Average Weekly Movement15.4%Software Industry Average Movement7.6%Market Average Movement5.5%10% most volatile stocks in SE Market11.2%10% least volatile stocks in SE Market3.1%安定した株価: OPSYHの株価は、 Swedish市場と比較して過去 3 か月間で変動しています。時間の経過による変動: OPSYHの weekly volatility ( 15% ) は過去 1 年間安定していますが、依然としてSwedishの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20077Arne Thorwww.opsy.seオプシー・ホールディングABは、医療と保険の交差点でソリューションを開発するハイテク企業である。同社は、保険金請求決済プロセスを開発・自動化するOpsyOneプラットフォームを提供している。同社のプラットフォームは、カスタマイズ可能なフォーム、品質保証とフィードバックループ、自動文書管理、データ分析と意思決定支援、医療記録の保存などの機能を提供する。保険会社や医療アドバイザーにサービスを提供している。同社は以前はWntResearch ABとして知られていたが、2025年4月にOpsy Holding ABに社名を変更した。Opsy Holding ABは2020年に設立され、スウェーデンのストックホルムを拠点としている。もっと見るOpsy Holding AB (publ) 基礎のまとめOpsy Holding の収益と売上を時価総額と比較するとどうか。OPSYH 基礎統計学時価総額SEK 147.74m収益（TTM）-SEK 12.34m売上高(TTM)SEK 11.19m13.2xP/Sレシオ-12.0xPER（株価収益率OPSYH は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計OPSYH 損益計算書（TTM）収益SEK 11.19m売上原価SEK 1.12m売上総利益SEK 10.07mその他の費用SEK 22.42m収益-SEK 12.34m直近の収益報告Mar 31, 2026次回決算日Aug 27, 2026一株当たり利益（EPS）-0.85グロス・マージン89.98%純利益率-110.29%有利子負債／自己資本比率-186.4%OPSYH の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/24 12:59終値2026/08/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Opsy Holding AB (publ) 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Aug 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.1m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr134.7m market cap, or US$14.2m).
お知らせ • Jul 29Opsy Holding AB (publ) to Report Q2, 2026 Results on Aug 27, 2026Opsy Holding AB (publ) announced that they will report Q2, 2026 results on Aug 27, 2026
Recent Insider Transactions • May 19CEO & Director recently bought kr161k worth of stockOn the 12th of May, Arne Thor bought around 17k shares on-market at roughly kr9.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr658k worth in shares.
Recent Insider Transactions • May 06CEO & Director recently bought kr139k worth of stockOn the 27th of April, Arne Thor bought around 18k shares on-market at roughly kr7.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr462k worth in shares.
New Risk • Apr 27New major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr587k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.2m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr97.1m market cap, or US$10.5m).
お知らせ • Apr 02Opsy Holding AB (publ) to Report Q1, 2026 Results on Apr 24, 2026Opsy Holding AB (publ) announced that they will report Q1, 2026 results on Apr 24, 2026
New Risk • Aug 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.1m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr134.7m market cap, or US$14.2m).
お知らせ • Jul 29Opsy Holding AB (publ) to Report Q2, 2026 Results on Aug 27, 2026Opsy Holding AB (publ) announced that they will report Q2, 2026 results on Aug 27, 2026
Recent Insider Transactions • May 19CEO & Director recently bought kr161k worth of stockOn the 12th of May, Arne Thor bought around 17k shares on-market at roughly kr9.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr658k worth in shares.
Recent Insider Transactions • May 06CEO & Director recently bought kr139k worth of stockOn the 27th of April, Arne Thor bought around 18k shares on-market at roughly kr7.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Arne has been a buyer over the last 12 months, purchasing a net total of kr462k worth in shares.
New Risk • Apr 27New major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr587k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.2m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-kr587k). Minor Risks Revenue is less than US$5m (kr11m revenue, or US$1.2m). Market cap is less than US$100m (kr97.1m market cap, or US$10.5m).
お知らせ • Apr 02Opsy Holding AB (publ) to Report Q1, 2026 Results on Apr 24, 2026Opsy Holding AB (publ) announced that they will report Q1, 2026 results on Apr 24, 2026
Recent Insider Transactions • Jan 16CEO & Director recently bought kr323k worth of stockOn the 13th of January, Arne Thor bought around 47k shares on-market at roughly kr6.91 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Arne's only on-market trade for the last 12 months.
お知らせ • Jan 13Opsy Holding AB (publ) to Report Fiscal Year 2025 Results on Feb 12, 2026Opsy Holding AB (publ) announced that they will report fiscal year 2025 results on Feb 12, 2026
お知らせ • Oct 29Opsy Holding AB to Report Q3, 2025 Results on Nov 27, 2025Opsy Holding AB announced that they will report Q3, 2025 results on Nov 27, 2025
お知らせ • Oct 16Opsy Holding AB announced that it expects to receive SEK 3.499991 million in funding from Juristfirma Erik Norman Aktiebolag, Alsteron ABOpsy Holding AB announced a private placement to issue 478,795 shares at a price of SEK 7.31 for aggregate gross proceeds of SEK 3,499,991.45 on October 15, 2025. The transaction will include participation from Erik Norman for 273,597 shares and Alsteron AB for 205,198 shares. The transaction has been approved by the board of directors and is subject to the Annual general Meeting of shareholders that is scheduled to be held on November 4, 2025. Post issuance, the share capital of the company will increase from SEK 12,218,223 to SEK 12,697,018.
お知らせ • Jul 23Opsy Holding AB to Report Q2, 2025 Results on Aug 21, 2025Opsy Holding AB announced that they will report Q2, 2025 results on Aug 21, 2025
お知らせ • Apr 29Opsy Holding AB to Report Q1, 2025 Results on May 28, 2025Opsy Holding AB announced that they will report Q1, 2025 results on May 28, 2025
